Analysts Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Price Target at $26.71
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating on […]
More Stories
Cigna Group (NYSE:CI) Upgraded at TD Cowen
TD Cowen upgraded shares of Cigna Group (NYSE:CI – Free Report) to a strong-buy rating in a report released on...
JPMorgan Chase & Co. Begins Coverage on Carlisle Companies (NYSE:CSL)
Investment analysts at JPMorgan Chase & Co. initiated coverage on shares of Carlisle Companies (NYSE:CSL – Get Free Report) in...
Dollar General (NYSE:DG) Rating Lowered to Neutral at The Goldman Sachs Group
Dollar General (NYSE:DG – Get Free Report) was downgraded by stock analysts at The Goldman Sachs Group from a “buy”...
Analysts Set Expectations for Kroger’s Q2 Earnings (NYSE:KR)
The Kroger Co. (NYSE:KR – Free Report) – Equities researchers at Telsey Advisory Group reduced their Q2 2026 earnings per...
Research Analysts Issue Forecasts for Sealed Air Q2 Earnings
Sealed Air Corporation (NYSE:SEE – Free Report) – Stock analysts at Zacks Research dropped their Q2 2026 EPS estimates for...
Alphabet (NASDAQ:GOOGL) Trading Up 1.5% on Analyst Upgrade
Shares of Alphabet Inc. (NASDAQ:GOOGL – Get Free Report) were up 1.5% during mid-day trading on Tuesday after Citigroup raised...